Glenmark Pharmaceuticals informs about media release

25 Apr 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release today titled ‘Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin + Pioglitazone Fixed-Dose Combination Drug for Type 2 Diabetes in India’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1987.45 -5.25 (-0.26%)
29-Jan-2026 10:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1590.35
Dr. Reddys Lab 1193.90
Cipla 1309.10
Zydus Lifesciences 884.50
Lupin 2100.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×